论文部分内容阅读
目的:比较喜炎平与利巴韦林注射液对小儿上呼吸道感染患者的临床疗效。方法:选取2012年11月—2014年11月间医院功能科诊治的小儿上呼吸道感染患儿120例,将随机分为对照组与治疗组,每组60例;对照组患者均给予利巴韦林注射液治疗,治疗组患者均给予喜炎平注射液治疗,比较两组患者治疗后的总有效率和症状改善情况。结果:治疗组患者治疗后临床症状改善时间明显短于对照组(P<0.05);治疗组患者临床治疗的总有效率为93.33%,显著高于对照组为83.33%(P<0.05);两组患者的不良反应发生率经比较其差异无统计学意义(P>0.05)。结论:采用喜炎平注射液治疗小儿上呼吸道感染患者的临床疗效优于利巴韦林注射液的疗效。
Objective: To compare the clinical effects of Xiyanping and Ribavirin in children with upper respiratory tract infection. Methods: A total of 120 children with upper respiratory tract infection were selected from November 2012 to November 2014 in our hospital, and randomly divided into control group and treatment group with 60 cases in each group. Patients in the control group were given ribavirin Lin injection, the treatment group were given Xiyanping injection treatment, the two groups were compared the total effective rate and symptom improvement. Results: The improvement of clinical symptoms in treatment group was shorter than that in control group (P <0.05). The total effective rate in treatment group was 93.33%, significantly higher than that in control group (83.33%, P <0.05); There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion: The clinical efficacy of Xiyanping injection in treating children with upper respiratory tract infection is better than ribavirin injection.